|
|
|
|
|
|
|
|
|
|
  |
 |
  |
ANE Regional Activities
>> Regional Overview >> ANE Regional Activities Overview ACTIVITY DATA SHEET
PROGRAM: Asia and the Near East Regional
TITLE AND NUMBER: Stabilize Population Growth and Protect Human Health, 498-022
STATUS: New
PLANNED FY 2001 OBLIGATION AND FUNDING SOURCE: $11,237,000 CSD
PROPOSED FY 2002 OBLIGATION AND FUNDING SOURCE: $ 300,000 DA; $10,400,000 CSD
INITIAL OBLIGATION: FY 2001 ESTIMATED COMPLETION DATE: ContinuingSummary: In FY 2001, this activity will replace the regional HIV/AIDS and Infectious Disease program (498-029) in order to provide a more integrated approach to regional health and population issues in the Asia and Near East (ANE) region.
Stabilization of population size and improved health and nutrition are essential to sustainable development. They also are fundamentally interdependent. When people are nourished and free from the ravages of infectious diseases, they can contribute more fully to their own social and economic progress and to that of their nation. Immunizations, health education, investments to correct micronutrient deficiencies, and investments in basic health services will significantly improve the health of people, especially women, children, and vulnerable populations. When couples can determine the size of their families, resources are made available at the household, national, and global levels for enduring improvements in quality of life. Moreover, improved health status of women and girls plays a critical role in child survival, family welfare, economic productivity, and population stabilization.
This activity will support the development of integrated interventions in maternal and child health, reproductive health, the reduced HIV transmission and the mitigation of the impact of the HIV/AIDS pandemic; improved management of other sexually transmitted infections (STIs); and improved capacity to combat, control, and prevent infectious diseases (IDs). Also, this activity will provide the resources to address the growing dimensions of population and health that are transboundary in nature. It will complement population and health programs in USAID presence and non-presence countries, and support the development of innovative models to promote best practices.
Key Results: This activity design is not yet finalized, but USAID anticipates that results will be similar to the old objective, "Asia and the Near East Regional HIV/AIDS and Infectious Disease Program" (498-029), i.e., focus on issues related to specific diseases such as HIV/AIDS, tuberculosis (TB), and malaria that are beyond the scope of individual country programs; provide the structure to integrate reproductive health and maternal and child health issues with those of HIV/AIDS and other infectious diseases; increase the number interventions to prevent, treat, or control IDs in mobile populations; expand the number of countries with national ID prevalence and behavioral surveillance systems; and increase the number of implementing partners adopting best practices or new ID services.
Performance and Prospects: Major components under this objective include: a) continuing HIV/AIDS activities; b) continuing infectious disease (ID) activities; c) new HIV/AIDS activities; d) new ID activities; and e) cross-cutting activities.
Continuing HIV/AIDS Activities ($3,160,000 CSD-HIV/AIDS): Activities begun in FY 2000 under SO 498-029 and continuing in FY 2001 under SO 498-022 include the following: (1) HIV and STI surveillance in border areas in the Mekong region; (2) a seafarers intervention project targeting ports in Indonesia and Thailand; (3) regional training to expand the capacity of community organizations to provide support for people living with AIDS; (4) cross-border HIV prevention programs in Nepal, India, and Thailand; (5) regional training for HIV program managers; (6) HIV/AIDS prevention activities in four provinces in Vietnam; (7) condom social marketing in Laos; and (8) an assessment of training needs for HIV voluntary counseling and testing programs in Vietnam, India, and Nepal.
Continuing Infectious Disease Activities ($2,102,000 CSD-ID): Activities begun in FY 2000 under SO 498-029 and continuing in FY 2001 under SO 498-022 include the following: (1) training on surveillance of drug-resistant malaria and related drug-use practices and drug quality in South and Southeast Asia; (2) developing and testing interventions, including new treatment regimens, to slow emergence and spread of drug-resistant malaria and improve the use of antimalarial drugs in Southeast Asia; and (3) standardizing surveillance and training methodologies for monitoring vector-borne diseases such as malaria in South Asia.
New HIV/AIDS Activities in FY 2001 ($3,342,000 CSD-HIV/AIDS and $997,000 ESF for East Timor): USAID will provide technical assistance to expand the capacity of public and private institutions throughout the region to become centers of excellence and the primary sources of technical assistance and training in a variety of disciplines (i.e., epidemiology, behavioral science, measurement and evaluation). USAID activities will also support the following: (1) pilot "pre-departure" HIV prevention programs in migrant communities in South and Southeast Asia; (2) support feasibility and planning studies and initiating an intervention to focus on the tens of thousands of workers from throughout Southeast Asia who will travel to/from Sihanoukville to build a seaport; (3) support policy dialogue with the governments, donors, and other partners on issues such as stigma, discrimination, and condom security; (4) undertake formative research studies in one country in South Asia or Southeast Asia on how to delay adolescent boys' sexual activity and positively change their attitudes about premarital sex and condom use; (5) provide a small grant to Morocco for a school-based HIV education program; (6) provide technical assistance to develop new HIV/AIDS prevention programs; (7) strengthen monitoring and evaluation of regional programs, especially those targeting mobile populations; (8) determine the impact of high-risk behaviors on HIV transmission; (9) mitigate stigma and discrimination against people living with HIV/AIDS; and (10) strengthen HIV education and STI treatment in reproductive health centers in Vietnam.
In FY 2001, USAID also will provide $997,000 in ESF funding to a cooperating agency to assist the U.N. agencies working in East Timor to "jump start" their proposed HIV and STI prevention programs.
New ID activities in FY 2001 ($1,829,000 CSD-ID): USAID plans to support the following: (1) develop a model to improve the use of health information for resource allocation; (2) standardize the collection, analysis, and reporting of surveillance and drug resistance information and related training in South and Southeast Asia; (3) improve TB lab training/quality assurance and provide technical assistance to missions and national TB programs; (4) and strengthen TB surveillance and expanding DOTS coverage. USAID will also support efforts to facilitate policy dialogue with international health organizations and industry to ensure that effective diagnostics and drug regimens for malaria are affordable and available to those in need.
New Cross-Cutting Activities ($400,000 CSD-HIV/AIDS; and $400,000 CSD-ID): In response to suggestions from USAID missions in the ANE region, USAID will support several new HIV and ID cross-cutting activities in FY 2001. In order to provide information on the short- and long-term social and economic impact of HIV/AIDS and infectious diseases, this activity will support scientific updates and advocacy workshops to provide data, materials and the skills needed to put HIV and infectious diseases on the development agenda as more than a health issue. USAID will also support limited numbers of technical meetings for USAID health officers, NGOs, selected government counterparts and cooperating agencies to keep them current on HIV/AIDS and ID developments such as changing epidemic trends, scientific breakthroughs and treatment improvements, and new programmatic approaches.
Possible Adjustments to Plans: Starting in FY 2001, this regional objective includes funding for and reporting on activities previously notified under the objective "ANE Regional HIV/AIDS and Infectious Diseases" (498-029). Population, reproductive health, maternal health and child survival activities may be expanded during FY 2002, including selected regional program activities that would complement bilateral programs and assist in the achievement of regional program goals.
Other Donor Programs: Key donors include the United Nations Joint Program on HIV/AIDS; the United Kingdom; the European Union; the United Nations Development Program; Japan; Australia; the Ford Foundation; Germany; the World Health Organization; and the World Bank.
Principal Contractors, Grantees, or Agencies: These activities will be implemented primarily through "buy-ins" to pre-competed USAID Global Bureau cooperative agreements and contracts. Partners in HIV/AIDS activities include: Family Health International/IMPACT, PSI/AIDSMARK, the International HIV/AIDS Alliance, and TVT Associates/SYNERGY. Infectious disease partners include: Abt Associates, Asian Collaborative Training Network for Malaria, Camp Dresser and McKee International, CARE, the Centers for Disease Control and Prevention, the Centre for Development and Population Activities/Technical Advisors in AIDS and Child Survival, the Johns Hopkins Health and Child Survival Fellowship Program, Kenan Institute of Asia, Management Sciences for Health, TB Coalition for Technical Assistance, the U.S. Pharmacopeia Convention, Inc., and the World Health Organization.
Selected Performance Indicators: Baseline
(2001)Target
(2006)Number of interventions targeting mobile populations implemented 5 7 Number of socially marketed condoms sold in non-presence countries (millions) 55 70 Innovative models developed and disseminated for prevention, treatment, care, and support of persons affected by HIV or IDs 6 8 U.S. Financing
(In thousands of dollars)
Obligations Expenditures Unliquidated Through September 30, 1999 0 DA 0 DA 0 DA 0 CSD 0 CSD 0 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA Fiscal Year 2000 0 DA 0 DA 0 CSD 0 CSD 0 ESF 0 ESF 0 SEED 0 SEED 0 FSA 0 FSA 0 DFA 0 DFA Through September 30, 2000 0 DA 0 DA 0 DA 0 CSD 0 CSD 0 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA Prior Year Unobligated Funds 0 DA 0 CSD 0 ESF 0 SEED 0 FSA 0 DFA Planned Fiscal Year 2001 NOA 0 DA 11,237 CSD 0 ESF 0 SEED 0 FSA 0 DFA Total Planned Fiscal Year 2001 0 DA 11,237 CSD 0 ESF 0 SEED 0 FSA 0 DFA Future Obligations Est. Total Cost Proposed Fiscal Year 2002 NOA 300 DA 1,500 DA 1,800 DA 10,400 CSD 20,570 CSD 42,207 CSD 0 ESF 0 ESF 0 ESF 0 SEED 0 SEED 0 SEED 0 FSA 0 FSA 0 FSA 0 DFA 0 DFA 0 DFA
 |
|||
Last Updated on: May 29, 2002 |
